tiprankstipranks
Trending News
More News >
Oncopeptides AB (SE:ONCO)
:ONCO
Sweden Market

Oncopeptides AB (ONCO) Financial Statements

Compare
0 Followers

Oncopeptides AB Financial Overview

Oncopeptides AB's market cap is currently kr310.56M. The company's EPS TTM is kr-0.287; its P/E ratio is ―; Oncopeptides AB is scheduled to report earnings on May 15, 2025, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenuekr 31.65Mkr 35.22Mkr 8.36Mkr 118.30Mkr 0.00
Gross Profitkr 28.98Mkr 36.30Mkr 8.35Mkr 65.17Mkr -14.40M
Operating Incomekr -283.50Mkr -253.45Mkr -349.35Mkr -1.42Bkr -1.59B
EBITDAkr -283.50Mkr -231.62Mkr -319.62Mkr -1.40Bkr -1.58B
Net Incomekr -284.61Mkr -249.11Mkr -337.95Mkr -1.43Bkr -1.59B
Balance Sheet
Cash & Short-Term Investmentskr 178.54Mkr 173.44Mkr 344.51Mkr 362.19Mkr 840.25M
Total Assetskr 244.19Mkr 238.38Mkr 385.32Mkr 439.38Mkr 946.76M
Total Debtkr 121.89Mkr 126.16Mkr 9.54Mkr 14.19Mkr 19.36M
Net Debtkr -56.64Mkr -47.25Mkr -334.97Mkr -347.99Mkr -820.90M
Total Liabilitieskr 189.91Mkr 181.60Mkr 91.03Mkr 228.51Mkr 369.86M
Stockholders' Equitykr 54.28Mkr 56.78Mkr 294.29Mkr 210.87Mkr 576.90M
Cash Flow
Free Cash Flowkr -260.57Mkr -279.61Mkr -423.02Mkr -1.52Bkr -1.31B
Operating Cash Flowkr -260.57Mkr -279.49Mkr -420.51Mkr -1.52Bkr -1.30B
Investing Cash Flowkr 496.00Kkr -116.00Kkr -2.51Mkr -339.00Kkr -20.13M
Financing Cash Flowkr 263.81Mkr 106.89Mkr 392.40Mkr 1.03Bkr 1.32B
Currency in SEK

Oncopeptides AB Earnings and Revenue History

Oncopeptides AB Debt to Assets

Oncopeptides AB Cash Flow

Oncopeptides AB Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis